{
    "Trade/Device Name(s)": [
        "Cytomics FC 500 MPL Flow Cytometer",
        "Cytomics FC 500 MCL Flow Cytometer",
        "FC 500 MPL",
        "FC 500 MCL",
        "FC 500"
    ],
    "Submitter Information": "Beckman Coulter Inc.",
    "510(k) Number": "K182886",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071681",
        "K030828"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "December 14, 2018",
    "Summary Letter Received Date": "December 17, 2018",
    "Submission Date": "December 14, 2018",
    "Regulation Number(s)": [
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Automated differential cell counter"
    ],
    "Analyte Class(es)": [
        "hematology",
        "immunology",
        "flow cytometry"
    ],
    "Analyte(s)": [
        "CD3+",
        "CD4+",
        "CD8+",
        "CD19+",
        "CD56+"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "12 x 75 mm tube",
        "12 x 77 mm tube",
        "24 well plate",
        "96 well plate"
    ],
    "Instrument(s)/Platform(s)": [
        "FC 500 MPL Flow Cytometer",
        "FC 500 MCL Flow Cytometer",
        "tetraCXP SYSTEM"
    ],
    "Method(s)/Technology(ies)": [
        "Flow cytometry",
        "Multi-parameter analysis",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Qualitative and quantitative cell analysis",
        "Simultaneous identification and enumeration of lymphocyte subpopulations"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for design change to Beckman Coulter Cytomics FC 500 MPL and MCL flow cytometers to add software risk controls for signal loss/drift detection.",
    "Indications for Use Summary": "For qualitative and quantitative measurement of biological and physical properties of cells and other particles, including identification and enumeration of lymphocyte subpopulations (CD3+, CD4+, CD8+, CD19+, CD56+) in whole blood using flow cytometry with specific monoclonal antibody reagents.",
    "fda_folder": "Hematology"
}